Operating Grant : Evaluation of Harm Reduction Approaches to Address the Opioid Crisis in the Context of COVID-19


Only one application will be accepted per available grant/funding pool. CRISM Node Principal Investigators will work with CRISM members to ensure a coordinated application to each pool, building on the networks of collaboration and cooperation across node/network members. Please refer to How to Apply for more details.

For an application to be eligible:

  1. The Nominated Principal Applicant must be an independent researcher.
  2. The Nominated Principal Applicant must be appointed at an eligible institution (see the CIHR Application Administration Guide – Part 4) by the effective date of funding.
  3. The Nominated Principal Applicant must be a member of the CRISM network. A letter of support from the appropriate CRISM regional node Nominated Principal Investigator (NPI) will be required to confirm eligibility (or from another Principal Investigator if the NPI is applying to this funding opportunity). See How to Apply for more information.
  4. A Nominated Principal Applicant can submit applications to both the Safer Supply Evaluation and one of the regional SCS Evaluations funding pools.
  5. The applying team must include a minimum of three individuals (including the Nominated Principal Applicant).
  6. Applicants to the Safer Supply Evaluation funding pool must not be directly involved in the operation of any of the SSPPs under evaluation, nor can an applicant/co-applicant to this evaluation be employed by Health Canada.
  7. Applicants to any of the regional SCS Evaluation funding pools must not be directly involved in the operation of the SCS under evaluation in their proposal.
  8. The Nominated Principal Applicant must have successfully completed one of the sex- and gender-based analysis training modules available online through the CIHR Institute of Gender and Health and have submitted a Certificate of Completion (see How to Apply section). Select and complete the training module most applicable to your research project.
  9. For any research applications involving First Nations, Inuit, Metis and/or Urban Indigenous populations, applicants must describe their experience working in an Indigenous Health Research environment. See How to Apply section for more details.
How to Apply: 

The specific objectives of this funding opportunity are to:

  • Inform best practices for the operation of safer supply interventions and supervised consumption sites
  • Address pressing evidence needs of decision makers and knowledge users in the area of harm reduction interventions, taking into consideration the impact of the COVID-19 pandemic and the local context
  • Consider the impact of the local context and other factors, such as biological and social determinants (e.g., sex, gender, age, housing status and income, etc.) and sub-populations (e.g., those with severe opioid use disorder, youth, Indigenous peoples, rural, inner-urban, etc.), on the interventions
  • Identify considerations for further evaluation activities of harm reduction interventions, including insights and generalizable knowledge regarding implementation processes, barriers, and facilitators
  • Advance evidence-based practices through knowledge dissemination activities
  • Foster cross-disciplinary collaboration and bilateral interaction with decision makers in order to directly inform drug policy
External Deadline: 
Thursday, November 12, 2020
Funding Source: 
Funding Level: